Content

Welcome to the CJU website » LOG IN

Details

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting
Dec  2019 (Vol.  26, Issue  6, Pages( 10045 - 10053)
PMID: 31860422

Abstract

Text-Size + 

  • No Abstract Available